期刊文献+

阿仑膦酸钠对小鼠骨质疏松骨折愈合的影响 被引量:5

下载PDF
导出
摘要 双膦酸盐类药物可有效地降低椎体骨折和非椎体骨折的发生风险。阿仑膦酸钠是应用最多的药物,作为一种氨基双膦酸盐,其可与骨重吸收表面的羟基磷灰石结合并抑制破骨细胞介导的骨重吸收[1]。发生骨折并行骨折内固定术后可否服用这种骨重吸收抑制剂,其骨折愈合进程是否有影响,目前尚无定论。本研究旨在通过卵巢切除小鼠骨折模型评价阿仑膦酸钠对骨质疏松骨折行骨折内固定术后骨折愈合的影响。
出处 《上海医学》 CAS CSCD 北大核心 2014年第9期808-810,I0005,共4页 Shanghai Medical Journal
  • 相关文献

参考文献9

  • 1钟伟,贺良.双膦酸盐类药物在骨折急性期患者中的应用[J].中国骨质疏松杂志,2007,13(7):511-515. 被引量:2
  • 2PETER C P, COOK W O, NUNAMAKER D M, et al. Effect of alendronate on fracture healing and bone remodeling in dogs[J]. J Orthop Res, 1996, 14(1) : 74-79.
  • 3CAO Y, MORI S, MASHIBA T, et al. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats[J]. J Bone Miner Res, 2002, 17(12): 2237-2246.
  • 4LI J, MORI S, KAJI Y, et al. Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats[J]. J Bone Miner Res, 1999, 14(6): 969-979.
  • 5LI C, MORI S, LI J, et al. Long-term effect of ineadronate disodlum (YM-175) on fracture healing of femoral shaft in growing rats[J]. J Bone Miner Res, 2001, 16(3) : 429-436.
  • 6GERSTENFELD L C, SACKS D J, PELIS M, et al. Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing[J]. J Bone Miner Res, 2009, 24(2): 196-208.
  • 7张胜利,王全平.骨质疏松性骨折愈合过程中骨痂局部生物力学的改变[J].第四军医大学学报,2001,22(11):1026-1028. 被引量:9
  • 8GERSTENFELD L C, LANDIS W J. Gene expression and extracellular matrix ultrastructure of a mineralizing chondrocyte cell eulture system[J]. J Cell Biol, 1991, 112 (3) : 501-513.
  • 9GUPTA H S, SCHRATTER S, TESCH W, et al. Two different correlations between nanoindentation modulus and mineral content in the bone-cartilage interface[J]. J Struct Biol, 2005, 149(2): 138-148.

二级参考文献46

  • 1吴在德.胃手术后评价.外科学(第五版)[M].北京:人民卫生出版社,2000.493-494.
  • 2Lu Y P,Practical orthopedics,1995年,27页
  • 3Yang G T,The medical biomechanics,1995年,97页
  • 4Lin Q Q,材料力学(第2版),1988年,151页
  • 5Russell RG,Rogers MJ.Bisphosphonates:From thelaboratory to the clinic and back again.J Bone,1999,25:97-106.
  • 6Palomo L,Bissada N,Liu J.Bisphosphonate therapy for bone loss in patients with osteoporosis and periodontal disease:clinical perspectives and review of the literature.Quintessence Int,2006,37(2):103-107.
  • 7Reszka AA,Rodan GA.Nitrogen-containing biphosphonate mechanism of action.Mini Bev Med Chem,2004,4(7):711-719.
  • 8Parfitt AM.Osteonal and hemi-osteonal remodeling.The spatial and temporal framework for signal traffic in adult human hone.J Cell Biochem,1994,55:273-286.
  • 9Frost HM.Intermediary organization of the skeleton.Boca Raton:CRC:1986.
  • 10Grynpas M.Age and disease-related changes in the mineral of bone.Calcif Tissue Int,1993,53(suppl.1):S57-S64.

共引文献9

同被引文献75

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部